J Neurol Sci. 2010 Feb 15; 289(1-2) : 93-103. Epub 2009 Sep 4. Restorative approaches in Parkinson’s Disease: which cell type wins the race? Meyer AK, Maisel M, Hermann A, Stirl K, Storch A. Department of Neurology, Dresden University of Technology, Dresden, Germany. Abstract Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder and is…

J Cell Biochem. 2010 Feb 1; 109(2) : 292-301. Human ES and iPS cells as cell sources for the treatment of Parkinson’s disease: current state and problems. Hwang DY, Kim DS, Kim DW. Stem Cell Research Center, 21C Frontier R&D Program of Ministry of Education, Science and Technology, Yonsei University Medical Center, Seoul, South Korea.…

J Clin Invest. 2010 Jan 4; 120(1): 29-40. doi: 10.1172/JCI40543. Stem cells in human neurodegenerative disorders–time for clinical translation? Lindvall O, Kokaia Z. Laboratory of Neurogenesis and Cell Therapy, Wallenberg Neuroscience Center, University Hospital, Lund, Sweden. olle.lindvall@med.lu.se Abstract Stem cell-based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of stem…

Brain Res. 2010 Jan 22; 1311 : 12-27. Epub 2009 Nov 26. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson’s disease. Cova L, Armentero MT, Zennaro E, Calzarossa C, Bossolasco P, Busca G, Lambertenghi Deliliers G, Polli E, Nappi G, Silani V, Blandini F. Department…

J Clin Invest. 2010 Jan 4; 120(1): 29-40. d oi: 10.1172/JCI40543. Stem cells in human neurodegenerative disorders–time for clinical translation? Lindvall O, Kokaia Z. Laboratory of Neurogenesis and Cell Therapy, Wallenberg Neuroscience Center, University Hospital, Lund, Sweden. olle.lindvall@med.lu.se Abstract Stem cell-based approaches have received much hype as potential treatments for neurodegenerative disorders. Indeed, transplantation of…

Ginekol Pol. 2009 Dec; 80(12) : 935-41. Physiological and pathological consequences of a presence of germ line stem cells in adult tissues -[Article in Polish] Ratajczak MZ, Machaliński B, Czajka R, Zuba-Surma E, Poziomkowska-Gesicka I, Słowik-Zyłka D. Zakład Fizjologii Katedry Fizjopatologii Pomorskiej Akademii Medycznej, Szczecin. mzrata01@louisville.edu Abstract Various therapheutic strategies employing stem cells have been…

Rinsho Shinkeigaku. 2009 Nov; 49(11) : 890-2. Cell therapy for Parkinson disease – [Article in Japanese] Muramatsu S. Division of Neurology, Jichi Medical University. Abstract Advances in the field of stem cell research have raised hopes of creating novel cell replacement therapies for Parkinson disease (PD), although double-blinded clinical trials have met with controversial success…

Rinsho Shinkeigaku. 2009 Nov; 49(11) : 834-6. Future of stem cell therapy for neuronal regeneration – [Article in Japanese] Takaha shi J . Department of Biological Repair, Institute for Frontier Medical Sciences, Kyoto University. Abstract Embryonic stem (ES) cells are expected as promising donor cells for cell transplantation therapy. For example, mouse or monkey ES…

Adv Exp Med Biol. 2010; 671 : 41-57. Stem cell transplantation methods. Tran KD, Ho A, Jandial R. UCSD School of Medicine, San Diego, California, USA. Abstract Just a few short years ago, we still used to think that we were born with a finite number of irreplaceable neurons. However, in recent years, there has…

J Neuroimmunol. 2009 Nov 30; 216(1-2) : 39-50. Epub 2009 Oct 9. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease. Chao YX, He BP, Tay SS. Department of Anatomy, Yong Loo Lin School of Medicine,…